Most MedTech sales teams aren’t using Artificial Intelligence for the work that actually moves the needle, even though those who do are three times more likely to hit quota. Salesforce’s 2026 State of Sales report found that sales teams using AI tools are 3.7 times more likely to meet targets than those who do not. Yet the data reveals a disconnect: most sales teams deploy AI for administrative chores like drafting emails and summarizing meetings instead of strategic tasks like identifying opportunities or prioritizing accounts.
Only 36% of MedTech representatives report using AI at work on a regular or occasional basis. That leaves nearly two-thirds of the sales force with no AI tools in their workflow. For those who do use the technology, the benefits are clear. AI users reported saving between four and six hours per week on administrative work, with more than a quarter estimating they save more than six hours on those tasks.
While those time savings are significant, they point to a different kind of problem. When asked what they would do with five to 10 additional hours every week, 62% of reps said they would spend the time preparing for calls and meetings, while 46% said they would spend it meeting with customers and prospects. The data suggests that sales teams want to reclaim time to do the work that directly influences outcomes, rather than just clearing their inboxes faster.
Read Also: FDA Tightens Cybersecurity and Quality Rules for Medical Devices
Administrative work remains a heavy burden for sales teams. A massive 84% of reps lose three to 10 hours a week to nonproductive tasks like documenting activities and updating CRM systems. The industry’s biggest challenges are not administrative; they are strategic. Survey respondents pointed to account prioritization, lack of market insights, and the difficulty of proving value to buyers as the main factors preventing them from hitting quota. When asked what would most improve their ability to grow pipeline, discovering new providers and identifying new opportunities topped the list.
This highlights a gap between the tools companies have and the problems they actually need to solve. As hospital consolidation concentrates purchasing power and purchasing decisions involve broader networks of administrators, finance teams, and supply chain leaders, the environment has become increasingly complex. Sales reps might have hundreds of potential opportunities within their territory, but only a limited number of hours to find them. In this environment, the real challenge is deciding what deserves attention in the first place.
The Opportunity They Miss
Consider a surgery cancellation that creates an unexpected opening in a sales rep’s day. According to the survey, 63% of respondents would turn to catching up on calls and emails. That seems reasonable given the tasks are waiting in the inbox. But imagine if instead the rep could immediately identify an account with declining procedure volume, uncover a high-potential physician who has not been visited in months, or spot a nearby opportunity showing signs of competitive encroachment. These are the kinds of decisions that influence pipeline growth and achieve quota. While one approach helps a rep complete tasks more quickly, the other helps a rep determine which opportunities deserve attention.
This distinction represents a fundamental shift in how organizations use AI to create value. The reason many AI initiatives stop with productivity is simple. Drafting an email is largely a language issue, but identifying the next best opportunity is a context issue. Most AI tools excel at language as they can summarize conversations and draft messages well. But MedTech commercialization operates within a highly specialized and complex environment. The issue is not a lack of technology, data, or information. Most companies have plenty of all three. The real challenge is turning fragmented information into actionable insight.
Read Also: How AI is uncovering hidden truths in medical device development
From Increased Productivity to Increased Intelligence
Most current AI systems function as assistants that respond to prompts and execute specific tasks. The next phase of development likely involves platforms that proactively identify opportunities, highlight risks, and suggest next steps before a sales representative even formulates a question. In many instances, the most effective AI operates quietly in the background, surfacing relevant data points and offering context precisely when a decision requires attention. Instead of merely helping a rep draft a message, the technology might determine which recipient should receive it. Rather than summarizing a conversation, it could help identify the next most valuable opportunity. The goal is to reveal which information holds the most importance, rather than simply organizing it.
The organizations that achieve the greatest competitive advantage will be those that transition beyond mere productivity gains and adopt real commercial intelligence. In a market characterized by growing complexity, limited time, and increasing competition, the capacity to identify the correct opportunity at the precise moment is far more valuable than saving a few minutes on administrative chores. For MedTech organizations, the path forward relies on a complex mixture of market forces, customer behavior, territory priorities, competitive activity, and organizational goals. Any technology that assists teams in handling this detailed environment will deliver the most significant long-term value.
Intelligence tools designed to reduce the time spent on research, planning, and data gathering enable teams to focus laser-like attention on activities that move the needle: building relationships, establishing trust, understanding customer needs, and helping providers adopt technologies that improve patient care.
